DONATE
DONATE →

Clinical trial 2026-526866-26-00 · Non-small cell lung cancer (NSCLC) and Head and neck squamous cell carcinoma

Strongers editorial cover for clinical study 2026-526866-26-00 (Phase IV), status: authorised — Non-small cell lung cancer (NSCLC) and Head and.
Oncology research 05 Oct 2026

2026-526866-26-00 — is «authorised» on CTIS (EU Clinical Trials Information System).

Clinical trial 2026-526866-26-00 (phase IV) is «authorised» on CTIS (EU Clinical Trials Information System).

Condition: Non-small cell lung cancer (NSCLC) and Head and neck squamous cell carcinoma · Registered interventions: PACLITAXEL, BEVACIZUMAB, GEMCITABINE, CETUXIMAB, PEMBROLIZUMAB · Recorded dates (source): 2026-09-30.

Source: https://euclinicaltrials.eu/ctis-public/view/2026-526866-26-00

A newsletter for those who compete, those who donate, those who believe in research

Events, awarded grants, stories of the people who make research possible. One email a month, no spam.